E-LIB Suche - Ergebnisse für: Di Pietrantonio, N

1

Epigenetically-driven persistence of inflammatory and oxida..:

Sanchez Ceinos, J ; Di Pietrantonio, N ; Shumliakivska, M...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

2

Epigenetic regulation of oxidative and inflammatory phenoty..:

Di Pietrantonio, N ; Shumliakivska, M ; Suades, R...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

3

Estrogen Receptor 1 (ESR1) and the Wnt/β-Catenin Pathway Me..:

Pelusi L ; Mandatori D ; Di Pietrantonio N...
info:eu-repo/semantics/altIdentifier/pmid/35956385. , 2022

Link: http://hdl.handle.net/11..

4

Endothelial cells from umbilical cord of women affected by ..:

Di Tomo P ; Alessio N ; Falone S...
info:eu-repo/semantics/altIdentifier/pmid/34046935. , 2021

Link: http://hdl.handle.net/11..

5

Calcimimetic R-568 vasodilatory effect on mesenteric vascul..:

Di Pietro N ; Potenza M. A ; Silvestre S. D...
info:eu-repo/semantics/altIdentifier/pmid/30092054. , 2018

Link: http://hdl.handle.net/11..

6

Calcimimetic R-568 vasodilatory effect effect on mesenteric..:

Di Pietro N ; Potenza MA ; Di Silvestre S...
info:eu-repo/semantics/altIdentifier/pmid/30092054. , 2018

Link: http://hdl.handle.net/11..

7

Applications to augment patient care for Internal Medicine ..:

Pietrantonio, F. ; Florczak, M. ; Kuhn, S....
Frontiers in Public Health. 12 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

8

34P Circulating tumor DNA (ctDNA) testing in tissue RAS/BRA..:

Rachiglio, A.M. ; Sacco, A. ; Amoroso, D....
Annals of Oncology. 35 (2024) - p. S18 , 2024

Link: https://doi.org/10.1016/..

9

109P Prognostic genomic signatures in RAS/BRAF mutant (mut)..:

Normanno, N. ; Damato, A. ; Esposito Abate, R....
Annals of Oncology. 35 (2024) - p. S50-S51 , 2024

Link: https://doi.org/10.1016/..

10

Plasmatic BRAF-V600E allele fraction as a prognostic factor..:

Ros, J. ; Matito, J. ; Villacampa, G....
Annals of Oncology. 34 (2023) 6 - p. 543-552 , 2023

Link: https://doi.org/10.1016/..

11

Cancer care in transgender and gender-diverse persons: resu..:

Leone, A.G. ; Miceli, R. ; Trapani, D....
ESMO Open. 8 (2023) 3 - p. 101578 , 2023

Link: https://doi.org/10.1016/..

12

Cetuximab as third‐line rechallenge plus either irinotecan ..:

Martini, G. ; Ciardiello, D. ; Famiglietti, V....
Cancer Medicine. 12 (2023) 8 - p. 9392-9400 , 2023

Link: https://doi.org/10.1002/..

13

Prognostic and predictive impact of consensus molecular sub..:

Borelli, B. ; Fontana, E. ; Giordano, M....
ESMO Open. 6 (2021) 2 - p. 100073 , 2021

Link: https://doi.org/10.1016/..

14

A POETIC Phase II study of continuous oral everolimus in re..:

Wright, Karen D. ; Yao, Xiaopan ; London, Wendy B....
Pediatric Blood & Cancer. 68 (2020) 2 - p. , 2020

Link: https://doi.org/10.1002/..

15

Towards an integrated approach for red mud valorisation: a ..:

Pietrantonio, M. ; Pucciarmati, S. ; Torelli, G. N....
International Journal of Environmental Science and Technology. 18 (2020) 2 - p. 455-462 , 2020

Link: https://doi.org/10.1007/..